Doxorubicin-induced vascular toxicity--targeting potential pathways may reduce procoagulant activity
about
Chemotherapy-induced vascular toxicity--real-time in vivo imaging of vessel impairment.Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular ToxicityCardiovascular disease among breast cancer survivors: the call for a clinical vascular health toolbox.Arterial stiffness in hematologic malignancies.The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity.
P2860
Doxorubicin-induced vascular toxicity--targeting potential pathways may reduce procoagulant activity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Doxorubicin-induced vascular t ...... y reduce procoagulant activity
@en
Doxorubicin-induced vascular t ...... reduce procoagulant activity.
@nl
type
label
Doxorubicin-induced vascular t ...... y reduce procoagulant activity
@en
Doxorubicin-induced vascular t ...... reduce procoagulant activity.
@nl
prefLabel
Doxorubicin-induced vascular t ...... y reduce procoagulant activity
@en
Doxorubicin-induced vascular t ...... reduce procoagulant activity.
@nl
P2093
P2860
P1433
P1476
Doxorubicin-induced vascular t ...... y reduce procoagulant activity
@en
P2093
Boris Shenkman
Hadas Bar Joseph
Irit Ben Aharon
Mattan Levi
Moran Tzabari
Nahid Farzam
Ruth Shalgi
Salomon M Stemmer
P2860
P304
P356
10.1371/JOURNAL.PONE.0075157
P407
P577
2013-09-20T00:00:00Z